Screening the molecular targets of ovarian cancer based on bioinformatics analysis

Lei Du1, Xiaolei Qian, Chenyang Dai

  • 1Department of Gynecology, the International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai - China.

Tumori
|May 9, 2015
PubMed
Abstract

Insights

This study identified 1136 differentially expressed genes (DEGs) in ovarian cancer (OC), revealing potential therapeutic targets like OGN, ZIC1, SOX17, and TFAP2A. These genes and functions related to oxygen transport and embryonic development may be crucial for OC development.

Area of Science:

  • Genomics
  • Oncology
  • Bioinformatics

Background:

  • Ovarian cancer (OC) is a highly lethal gynecologic malignancy.
  • Understanding OC's molecular mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To explore the molecular mechanisms underlying ovarian cancer.
  • To identify potential molecular targets for OC treatment.

Main Methods:

  • Gene expression data from 12 normal and 12 OC ovarian surface epithelia samples were analyzed.
  • Differentially expressed genes (DEGs) were identified using limma package in R.
  • Protein-protein interaction (PPI) networks were constructed and analyzed using Cytoscape and DAVID for functional enrichment.

Main Results:

  • A total of 1136 DEGs were identified (592 upregulated, 544 downregulated).
  • Key DEGs (CDKN2A, MUC1, OGN, ZIC1, SOX17, TFAP2A) showed interactions with known OC-related genes.
  • Enriched functions for downregulated DEGs included oxygen transport and embryonic development.

Conclusions:

  • OGN, ZIC1, SOX17, and TFAP2A, along with oxygen transport and embryonic development functions, are proposed to play a role in OC development.
  • These identified DEGs and associated genes represent potential therapeutic targets for ovarian cancer.
  • Further research is needed to validate these findings and their therapeutic potential.